Skip to content

PROMISC: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PROMISC

BE 0896.714.322
NACE 72.101, Research and development on biotechnology
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€6,303
2024 · €3,225-€9,528
Equity
-€5,625
2024 · €677-€6,303
Cash
€18,300
2024 · €11,306+€6,994
Balance sheet total
€82,953
2024 · €68,730+€14,223

Largest movements

2024 to 2025
Assets
  • Stocks and contracts +€20,127

    up €20,127 (+99.6%), from €20,205 to €40,332

  • Receivables within one year -€11,360

    down €11,360 (-33.7%), from €33,736 to €22,376

    of which Trade receivables: -€15,071

  • Cash +€6,994

    up €6,994 (+61.9%), from €11,306 to €18,300

    mainly Trade debts (+€22,259) and Receivables within one year (+€11,360)

  • Intangible fixed assets -€1,528

    down €1,528 (-46.5%), from €3,287 to €1,759

Equity and liabilities
  • Trade debts +€22,259

    up €22,259 (+88.6%), from €25,129 to €47,388

  • Accrued charges and deferred income -€6,733

    down €6,733 (-20.5%), from €32,924 to €26,190

  • Profit (loss) carried forward -€6,303

    down €6,303 (-31.6%), from -€19,940 to -€26,243

  • Short-term financial debts +€5,000

    up €5,000 (+100.0%), from €5,000 to €10,000

Income statement
  • Gross operating margin -€11,900

    down €11,900, from €8,441 to -€3,459

  • Financial charges -€1,235

    down €1,235 (-53.2%), from €2,322 to €1,087

  • Depreciation -€474

    down €474 (-23.6%), from €2,011 to €1,537

  • Other operating charges -€378

    down €378 (-39.5%), from €958 to €580

  • Financial income +€285

    up €285 (+376.7%), from €76 to €360

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €3,225
Gross operating margin -€11,900
Depreciation +€474
Other operating charges +€378
Financial income +€285
Financial charges +€1,235
Result 2025 -€6,303

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€1,994
Investment €0
Financing +€5,000
Cash 2024 €11,306
Net result for the year -€6,303
Depreciation +€1,537
Stocks and contracts -€20,127
Receivables within one year +€11,360
Trade debts +€22,259
Accrued charges and deferred income -€6,733
Short-term financial debts +€5,000
Cash 2025 €18,300
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €68,730 €82,953 +€14,223 +20.7%
Fixed assets 21/28 €3,483 €1,945 -€1,537 -44.1%
Intangible fixed assets 21 €3,287 €1,759 -€1,528 -46.5%
Tangible fixed assets 22/27 €9 €0 -€9 -100.0%
Furniture and vehicles 24 €9 €0 -€9 -100.0%
Financial fixed assets 28 €186 €186 = 0.0%
Current assets 29/58 €65,247 €81,007 +€15,760 +24.2%
Stocks and contracts in progress 3 €20,205 €40,332 +€20,127 +99.6%
Stocks 30/36 €20,205 €40,332 +€20,127 +99.6%
Amounts receivable within one year 40/41 €33,736 €22,376 -€11,360 -33.7%
Trade receivables 40 €25,862 €10,792 -€15,071 -58.3%
Other amounts receivable 41 €7,874 €11,584 +€3,710 +47.1%
Cash at bank and in hand 54/58 €11,306 €18,300 +€6,994 +61.9%
Total equity and liabilities 10/49 €68,730 €82,953 +€14,223 +20.7%
Equity 10/15 €677 -€5,625 -€6,303
Contributions 10/11 €20,000 €20,000 = 0.0%
Reserves 13 €618 €618 = 0.0%
Distributable reserves 133 €618 €618 = 0.0%
Profit (loss) carried forward 14 -€19,940 -€26,243 -€6,303 -31.6%
Amounts payable 17/49 €68,052 €88,578 +€20,526 +30.2%
Amounts payable after more than one year 17 €5,000 €5,000 = 0.0%
Other amounts payable 178/9 €5,000 €5,000 = 0.0%
Amounts payable within one year 42/48 €30,129 €57,388 +€27,259 +90.5%
Financial debts 43 €5,000 €10,000 +€5,000 +100.0%
Credit institutions 430/8 €5,000 €10,000 +€5,000 +100.0%
Trade debts 44 €25,129 €47,388 +€22,259 +88.6%
Suppliers 440/4 €25,129 €47,388 +€22,259 +88.6%
Accrued charges and deferred income 492/3 €32,924 €26,190 -€6,733 -20.5%
Non-recurring operating income 76A €9,754 €0 -€9,754 -100.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,011 €1,537 -€474 -23.6%
Other operating charges 640/8 €958 €580 -€378 -39.5%
Gross operating margin 9900 €8,441 -€3,459 -€11,900
Operating profit (loss) 9901 €5,472 -€5,576 -€11,048
Financial income 75/76B €76 €360 +€285 +376.7%
Recurring financial income 75 €76 €360 +€285 +376.7%
Financial charges 65/66B €2,322 €1,087 -€1,235 -53.2%
Recurring financial charges 65 €2,322 €1,087 -€1,235 -53.2%
Profit (loss) for the period before taxes 9903 €3,225 -€6,303 -€9,528
Profit (loss) for the period 9904 €3,225 -€6,303 -€9,528
Profit (loss) for the period to be appropriated 9905 €3,225 -€6,303 -€9,528

Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.